Vaxart, Inc. Public Float
Vaxart, Inc. (VXRT) had Public Float of $102.71 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $102.71M.
- 2024-06-30: Entity Public Float $150.84M.
- 2023-06-30: Entity Public Float $110.32M.
- 2022-06-30: Entity Public Float $393.57M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $102.71M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $150.84M 10-K · filed 2025-03-20 |
| 2023-06-30 | $110.32M 10-K · filed 2024-03-14 |
| 2022-06-30 | $393.57M 10-K · filed 2023-03-15 |
| 2021-06-30 | $913.15M 10-K · filed 2022-02-24 |
| 2020-06-30 | $842.05M 10-K · filed 2021-02-25 |
| 2019-06-30 | $8.32M 10-K · filed 2020-03-19 |
| 2018-06-30 | $12.18M 10-K · filed 2019-02-06 |
| 2016-12-31 | $47.10M 10-K · filed 2017-09-01 |
| 2015-12-31 | $74.20M 10-K · filed 2016-09-13 |
| 2014-12-31 | $78.10M 10-K · filed 2015-09-11 |
| 2013-12-31 | $117.80M 10-K · filed 2014-09-30 |
| 2013-06-30 | $86.22M 10-K · filed 2013-09-27 |
| 2011-06-25 | $216.84M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |